158 related articles for article (PubMed ID: 19923742)
21. Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes.
Nandi P; Li S; Columbres RCA; Wang F; Williams DR; Poh YP; Chou TF; Chiu PL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360842
[TBL] [Abstract][Full Text] [Related]
22. Rescue of growth defects of yeast cdc48 mutants by pathogenic IBMPFD-VCPs.
Takata T; Kimura Y; Ohnuma Y; Kawawaki J; Kakiyama Y; Tanaka K; Kakizuka A
J Struct Biol; 2012 Aug; 179(2):93-103. PubMed ID: 22728077
[TBL] [Abstract][Full Text] [Related]
23. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Weihl CC; Miller SE; Hanson PI; Pestronk A
Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
[TBL] [Abstract][Full Text] [Related]
24. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
[TBL] [Abstract][Full Text] [Related]
25. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling.
Viassolo V; Previtali SC; Schiatti E; Magnani G; Minetti C; Zara F; Grasso M; Dagna-Bricarelli F; Di Maria E
Clin Genet; 2008 Jul; 74(1):54-60. PubMed ID: 18341608
[TBL] [Abstract][Full Text] [Related]
26. Cross-sectional study of patients with VCP multisystem proteinopathy 1 using dual-energy x-ray absorptiometry.
Columbres RCA; Luu V; Nguyen M; Kimonis V
Muscle Nerve; 2024 Jun; 69(6):699-707. PubMed ID: 38551101
[TBL] [Abstract][Full Text] [Related]
27. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
Weihl CC; Pestronk A; Kimonis VE
Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
[TBL] [Abstract][Full Text] [Related]
28. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.
Guinto JB; Ritson GP; Taylor JP; Forman MS
Acta Neuropathol; 2007 Jul; 114(1):55-61. PubMed ID: 17457594
[TBL] [Abstract][Full Text] [Related]
29. [Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia].
Hayashi Y
Rinsho Shinkeigaku; 2013; 53(11):947-50. PubMed ID: 24291843
[TBL] [Abstract][Full Text] [Related]
30. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
[TBL] [Abstract][Full Text] [Related]
31. Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings.
Kumar KR; Needham M; Mina K; Davis M; Brewer J; Staples C; Ng K; Sue CM; Mastaglia FL
Neuromuscul Disord; 2010 May; 20(5):330-4. PubMed ID: 20335036
[TBL] [Abstract][Full Text] [Related]
32. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
Ritson GP; Custer SK; Freibaum BD; Guinto JB; Geffel D; Moore J; Tang W; Winton MJ; Neumann M; Trojanowski JQ; Lee VM; Forman MS; Taylor JP
J Neurosci; 2010 Jun; 30(22):7729-39. PubMed ID: 20519548
[TBL] [Abstract][Full Text] [Related]
33. Crystal structures of the UBX domain of human UBXD7 and its complex with p97 ATPase.
Li ZH; Wang Y; Xu M; Jiang T
Biochem Biophys Res Commun; 2017 Apr; 486(1):94-100. PubMed ID: 28274878
[TBL] [Abstract][Full Text] [Related]
34. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system.
Ju JS; Weihl CC
Autophagy; 2010 Feb; 6(2):283-5. PubMed ID: 20083896
[No Abstract] [Full Text] [Related]
35. Proteomic analysis of a drosophila IBMPFD model reveals potential pathogenic mechanisms.
Chan HT; Lee TR; Huang SH; Lee HY; Sang TK; Chan HL; Lyu PC
Mol Biosyst; 2012 Jun; 8(6):1730-41. PubMed ID: 22481368
[TBL] [Abstract][Full Text] [Related]
36. Insights into the Design of p97-targeting Small Molecules from Structural Studies on p97 Functional Mechanism.
Sui X; Pan M; Li YM
Curr Med Chem; 2020; 27(2):298-316. PubMed ID: 31584361
[TBL] [Abstract][Full Text] [Related]
37. Purification, crystallization and preliminary X-ray analysis of human pirin.
Zeng Q; Li X; Bartlam M; Wang G; Pang H; Rao Z
Acta Crystallogr D Biol Crystallogr; 2003 Aug; 59(Pt 8):1496-8. PubMed ID: 12876364
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic variability in three families with valosin-containing protein mutation.
Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
[TBL] [Abstract][Full Text] [Related]
39. The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1).
Johnson MA; Klickstein JA; Khanna R; Gou Y; ; Raman M
Neurobiol Dis; 2022 Jul; 169():105722. PubMed ID: 35405261
[TBL] [Abstract][Full Text] [Related]
40. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
